Well, isn’t that generous? The Group Insurance Advisory Committee (GIAC), under the Office of Group Insurance (OGI) within the Department of Administration — ever the example of fiscal responsibility — unilaterally decided to extend the GLP-1 weight-loss drugs to the employee health benefits plan for the previous few years. But don’t worry, when it was […]| Idaho Freedom
Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s room for many MASH drugs with the treatment landscape expected to shape up to include combinations of therapies bringing different approaches to this fatty liver disease.| MedCity News
Here are five guidelines to help employers balance health outcomes and financial responsibility to ensure that GLP-1 coverage is effective, affordable, and aligned with improved health and workforce well-being for employees and their families.| MedCity News
The CEO of a $7.8 billion asset manager says his firm is investing in three companies poised to drive transformative advancements in healthcare, financial data and AI.| The Daily Hodl
